Quick Answer
InMed Pharmaceuticals Inc. reported Shares Outstanding of 2.00 million shares for fiscal year 2025.
InMed Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.00M | +349.0% |
| 2024 | 445,908 | -86.6% |
| 2023 | 3.33M | +411.5% |
| 2022 | 650,667 | +102.1% |
| 2021 | 322,028 | -93.8% |
| 2020 | 5.22M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 2.80M | +287.2% | +7.7% |
| September 30, 2025 | 2.60M | +290.4% | +30.1% |
| June 30, 2025 | 2.00M | +349.0% | +65.9% |
| March 31, 2025 | 1.21M | -81.0% | +66.7% |
| December 31, 2024 | 724,152 | -87.2% | +8.6% |
| September 30, 2024 | 667,013 | -80.0% | +49.6% |
| June 30, 2024 | 445,908 | -86.6% | -93.0% |
| March 31, 2024 | 6.34M | +90.6% | +11.9% |
- InMed Pharmaceuticals Inc. showed an increase of +349.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, InMed Pharmaceuticals Inc.’s shares outstanding has declined by 61.6% (from 5.22 million shares to 2.00 million shares).
- The most recent figure is from InMed Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: